News

Unity Software’s bottom-line estimates for 2025 and 2026 have contracted over the past 30 days to a loss per share of 80 ...
LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multiprotein complex that has bipartite DNA binding through ...
A new study from Guest Metrics, which has a vested interest in selling content filtering solutions, claims to have identified ...
Young Americans are being asked to unwittingly face off against an algorithm that is likely a tool of Chinese intelligence ...
Amazon's AWS division made several strategic announcements during the second quarter that positioned the company to ...
In less than six months, Toronto’s world-class Blue Box program will be fully privatized and the city will no longer manage ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced a strategic restructuring plan ...